N., Wharton, S., Connery, L., Alves, B.,
Background There were two GLP-1 products that were initially approved and marketed for treating type-2 diabetes but, because they also had successful weight loss results, the manufacturers each got FDA approval to sell the products under two separate indications, one indicated for type 2 diabetes and one for weight loss, each with its own brand name and National Drug Code (NDC) identification number
According to the FDA prescribing information, these include nausea, vomiting, diarrhea, abdominal pain, and constipation
Key Takeaways for Starting GLP-1 Therapy Starting GLP-1 medication is a significant step toward better health and body confidence
Elisa RAW264.7 cells (3 10 5 cells per well) pre-treated with LPS (1 g mL 1 ) for 24 h and untreated HUVECs (3 10 5 cells per well) were incubated with different materials for 24 h
Feeling grounded and well